3-Bromo-2-methyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 250mg

((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)methanol, 95.0%, 5g

(S)-1-(tert-Butoxycarbonyl)-2-methylpiperidine-2-carboxylic acid, 95.0%, 100mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-ethoxypropanoic acid, 98%, 5g

L-Histidin, min. 98,5 %, Ph.Eur., für die Biochemie, 25 g, kunststoffverpackung.

N1,N1-Dimethyl-4-(trifluoromethyl)benzene-1,2-diamine, 95.0%, 5g

2-(Chloromethyl)-3-methylpyrazine Hydrochloride, 95.0%, 1g

N-(Adamantan-1-yl)acetamide, 95.0%, 25g

2-Formamidoacetic acid, 95.0%, 500g

tert-Butyl ((1R,3R)-3-hydroxycyclopentyl)carbamate, 95.0%, 5g

2-Fluorophenyl methyl carbinol, 97.0%, 10g

Rotilabo®-Glasstäbe, Borosilikatglas, L 250 mm, Ø 8 mm, 10 Stück

1-(4-(Trifluoromethyl)phenyl)pyrrolidine, 97%, 250mg